Nazione: Regno Unito
Lingua: inglese
Fonte: MHRA (Medicines & Healthcare Products Regulatory Agency)
Isosorbide mononitrate
Advanz Pharma
C01DA14
Isosorbide mononitrate
60mg
Modified-release tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02060100; GTIN: 5021730002046
102402/LF/011/01 1000011758 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT CHEMYDUR ® 60XL TABLETS Isosorbide-5-mononitrate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse has told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. - You must talk to a doctor if you do not feel better or if you feel worse. WHAT IS IN THIS LEAFLET: 1. What Chemydur 60XL Tablets are and what they are used for 2. What you need to know before you take Chemydur 60XL Tablets 3. How to take Chemydur 60XL Tablets 4. Possible side effects 5. How to store Chemydur 60XL Tablets 6. Contents of the pack and other information 1. WHAT CHEMYDUR 60XL TABLETS ARE AND WHAT THEY ARE USED FOR The name of your medicine is Chemydur 60XL Tablets. The active ingredient is isosorbide-5-mononitrate. Chemydur 60XL Tablets belong to a group of medicines called nitrates. Chemydur 60XL Tablets are used in adults to prevent angina (chest pain) and work by opening up blood vessels and reducing the pain. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE CHEMYDUR 60XL TABLETS DO NOT TAKE CHEMYDUR 60XL TABLETS IF YOU: • are allergic to isosorbide-5-mononitrate or any of the other ingredients of this medicine (listed in section 6). (Allergic reactions include mild symptoms such as itching and/or rash. More severe symptoms include swelling of the face, lips, tongue and/or throat with difficulty in swallowing or breathing); • have any inflammation of the heart such as pericarditis; • have been diagnosed with any of the following heart conditions - Low cardiac filling pressure - Cardiac tamponade - Hypertrophic obstructive cardiomyopathy; • have had any serious damage to your Leggi il documento completo
OBJECT 1 CHEMYDUR 60XL TABLETS Summary of Product Characteristics Updated 29-Jan-2020 | ADVANZ Pharma • 1. Name of the medicinal product • 2. Qualitative and quantitative composition • 3. Pharmaceutical form • 4. Clinical particulars • 4.1 Therapeutic indications • 4.2 Posology and method of administration • 4.3 Contraindications • 4.4 Special warnings and precautions for use • 4.5 Interaction with other medicinal products and other forms of interaction • 4.6 Fertility, pregnancy and lactation • 4.7 Effects on ability to drive and use machines • 4.8 Undesirable effects • 4.9 Overdose • 5. Pharmacological properties • 5.1 Pharmacodynamic properties • 5.2 Pharmacokinetic properties • 5.3 Preclinical safety data • 6. Pharmaceutical particulars • 6.1 List of excipients • 6.2 Incompatibilities • 6.3 Shelf life • 6.4 Special precautions for storage • 6.5 Nature and contents of container • 6.6 Special precautions for disposal and other handling • 7. Marketing authorisation holder • 8. Marketing authorisation number(s) • 9. Date of first authorisation/renewal of the authorisation • 10. Date of revision of the text 1. Name of the medicinal product Chemydur 60XL Mitrate 60XL 2. Qualitative and quantitative composition Each tablet contains 60 mg of isosorbide-5-mononitrate. International non-proprietary name (INN): Isosorbide mononitrate. Chemical name: 1,4 : 3,6 dianhydro-D-glucitol-5-nitrate. Excipients with known effect: Lactose (38.167 mg/ tablet) For the full list of excipients, see section 6.1. 3. Pharmaceutical form Tablets (modified release). Oval, cream coloured tablets, half scored on both sides and marked with a crown and 60 on one side. 4. Clinical particulars 4.1 Therapeutic indications Chemydur 60XL Tablets/Mitrate 60XL Tablets are indicated in adults for the prophylactic treatment of angina pectoris 4.2 Posology and method of administration Posology Adults One tablet (60 mg) once daily given in the morning. The dose may be increased to two tablets (120 m Leggi il documento completo